Micar Innovation (Micar21) is the winner of а prestigious award for Innovative startup enterprise of the year 2018

The National Competition “Innovative Enterprise of the Year” annually awards Bulgarian enterprises with successfully implemented innovative products, processes, services and practices on the Bulgarian and world markets.

Тhe 14th edition of the competition “Innovative Enterprise of the Year – 2018” took place during the National Innovation Forum on 6 December 2018.

The Forum with the participation of the President of the Republic of Bulgaria Mr. Rumen Radev features the award ceremony of the Innovative Enterprise of the Year 2018 national contest..

For Innovative New Startup Enterprise, Micar Innovation (Micar21) was awarded an honorary certificate.

Source: Applied Research and Communications Fund

Source: Applied Research and Communications Fund

Source: Applied Research and Communications Fund

About Innovative Enterprise of the Year – 2018 - more information: Innovative Enterprise of the Year – 2018

Micar Innovation is a drug discovery factory. The company has found a niche where it is able to create a large societal impact by improving the quality of life through new blockbuster drug molecules for a large class of diseases. Micar Innovation focuses on non-clinical Proof-of-Concepts (POCs) in preclinical R&D and Hit-to-Lead (H2L) achievements in areas such as neuroscience, oncology, cardio-vascularity, dermatology, rare diseases. Micar21 is our drug discovery platform for small molecule drug candidates. The business model is based on licensing our intellectual property to commercial partners and on the creation new spin out companies.

“European CIDIC Award”

Micar Innovation (Micar21) has been awarded a “European CIDIC Award”

We are delighted to introduce DEAC (Diplomatic, Economic, Academic and Cultural) days concept organised during each bi-annual presidency of the Council of the EU which is currently BULGARIA.

The CIDIC jury, composed of its board of directors, professors of the Vrij Universiteit Brussel (VUB), representatives of the Bulgarian Embassy in Brussels, is pleased to inform that Micar Innovation (Micar21) has been awarded a “European CIDIC Award”.

This Award has handed over at the BCCI during our DEAC days in Sofia and you are cordially invited to collect yours during the ceremony followed by a reception organised by the Belgian Ambassador in his residence on TUESDAY 24th APRIL 2018 from 16:30

Micar Innovation received the CIDIC award for its well-chosen positioning in a complex and long value chain, where it can create key-value contributions by delivering non-clinical POCs. The company can be qualified as a fountain of intellectual property and an IP broker for new pharma startups and big pharma industry.

About CIDIC: CIDIC is the European Centre of Economic Diplomacy and addresses the Diplomatic, Economic, Academic and Cultural world. CIDIC facilitates meetings between the actors of these worlds to promote, in an informal way, privileged relationships. CIDIC fosters improved awareness and common activities among decision-makers in these different spheres through DEAC Missions (Diplomatic-Economic-Academic-Cultural) to the countries presiding the Council of the European Union on a rotating basis, thematic conferences and receptions. CIDIC is supported by UNICA (Network of Universities from the Capitals of Europe), the Brussels Diplomatic Academy, the Diplomatic World Magazine and the Belgian Ministry of Foreign Affairs. Baron Ernest de Laminne de Bex ( President) - more information: www.cidic.be

Micar Innovation is a drug discovery factory. The company has found a niche where it is able to create a large societal impact by improving the quality of life through new blockbuster drug molecules for a large class of diseases. Micar Innovation focuses on non-clinical Proof-of-Concepts (POCs) in preclinical R&D and Hit-to-Lead (H2L) achievements in areas such as neuroscience, oncology, cardio-vascularity, dermatology, rare diseases. Micar21 is our drug discovery platform for small molecule drug candidates. The business model is based on licensing our intellectual property to commercial partners and on the creation new spin out companies.

Micar Innovation received the CIDIC award for its well-chosen positioning in a complex and long value chain, where it can create key-value contributions by delivering non-clinical POCs. The company can be qualified as a fountain of intellectual property and an IP broker for new pharma startups and big pharma industry.

Best Biotech Startup of the year 2017 in CEE

Micar Innovation (Micar21) named Best Biotech Startup of the year 2017 in CEE - Bulgaria National Winners

On the 4th edition of the Central European Startup Awards finals, competition that includes national finalists from 10 countries in Central and Eastern Europe, Micar Innovation (Micar21) was named Best Biotech Startup of the year in CEE - Bulgaria National Winners.

The Central European Startup Awards launched in 2014 and covers currently 10 countries (Austria, Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Serbia, Slovakia and Slovenia). The initiative has become the region’s largest startup festival, spotlighting the best entrepreneurs and investors across the region. The CESA have been steadily growing in popularity, with last year’s event receiving over 800 nominations.